These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30580375)

  • 1. Sodium transport in diabetes: two sides to the coin.
    Lovshin JA; Cherney DZ
    Nat Rev Nephrol; 2019 Mar; 15(3):125-126. PubMed ID: 30580375
    [No Abstract]   [Full Text] [Related]  

  • 2. [Two types of diabetes mellitus; diabetes with glucagon hyperglycemia and diabetes with disturbed insulin utilization].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1953 Feb; 8(3):126-35. PubMed ID: 13078853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glucagon hyperglycemia and disordered insulin utilization in diabetes mellitus in man].
    KLOTZBUCHER E
    Dtsch Gesundheitsw; 1952 Nov; 7(47):1487. PubMed ID: 13043283
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon: role in the hyperglycemia of diabetes mellitus.
    Dobbs R; Sakurai H; Sasaki H; Faloona G; Valverde I; Baetens D; Orci L; Unger R
    Science; 1975 Feb; 187(4176):544-7. PubMed ID: 1089999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia-glycogenolytic factor in diabetic man and alloxan-diabetic animals.
    OSMAN SAKA M
    Am J Physiol; 1952 Nov; 171(2):401-6. PubMed ID: 13007809
    [No Abstract]   [Full Text] [Related]  

  • 6. [MORPHOLOGICAL PROBLEMS IN DIABETES RESEARCH].
    SCHULTRICH S
    Z Gesamte Inn Med; 1964 Aug; 19():641-9. PubMed ID: 14241493
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GLUCAGON. CLINICAL STUDY OF ITS HYPERGLYCEMIC ACTION].
    CANIVET J; POIRIER J
    Pathol Biol; 1964 Mar; 12():296-303. PubMed ID: 14146249
    [No Abstract]   [Full Text] [Related]  

  • 9. [EFFECT OF GLUCAGON ON BLOOD GLUCOSE AND PLASMA NON-ESTERIFIED FATTY ACIDS CONCENTRATIONS].
    KOYAMA S
    Nihon Naika Gakkai Zasshi; 1964 Apr; 53():9-20. PubMed ID: 14179115
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON QUANTITATIVE STUDIES OF THE GLYCOGEN CONTENT OF THE LIVER IN HEALTHY AND DISEASED SUBJECTS. 3. ACTION MECHANISM OF GLUCAGON].
    BERINGER A; THALER H
    Wien Med Wochenschr; 1965 Feb; 115():105-7. PubMed ID: 14260959
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
    Unger RH; Orci L
    Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
    [No Abstract]   [Full Text] [Related]  

  • 12. [STUDY OF GLUCIDE BEHAVIOR IN PREGNANCY DURING THE GLUCAGON TEST].
    MANFREDI P
    Rass Int Clin Ter; 1964 Jul; 44():717-22. PubMed ID: 14176672
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.
    Gerich JE; Lorenzi M; Karam JH; Schneider V; Forsham PH
    JAMA; 1975 Oct; 234(2):159-5. PubMed ID: 1242153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin and diabetes mellitus: the role of glucagon in diabetic hyperglycemia and glucose intolerance.
    Wahren J
    Scand J Clin Lab Invest; 1976 Oct; 36(6):497-503. PubMed ID: 1006141
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glucagon in the pathogenesis of diabetes: the status of the controversy.
    Unger RH
    Metabolism; 1978 Nov; 27(11):1691-709. PubMed ID: 360007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EXPERIMENTAL DIABETES AND THE MODE OF ACTION OF THE SULFONYLUREAS. WITH SOME SPECULATIONS ON THE PREVENTION OF DIABETES.
    FOA PP
    Bull Sinai Hosp Detroit; 1964; 12():31-46. PubMed ID: 14156394
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of glucagon in hyperglycemia. A review (author's transl)].
    Luyckx A
    Diabete Metab; 1975 Sep; 1(3):201-8. PubMed ID: 791728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A current concept of the pathophysiology of the hyperglycemia of diabetes mellitus.
    Skillmann TG
    W V Med J; 1976 Sep; 72(9):247-50. PubMed ID: 1067686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.